![background image](http://html1.mh-extra.com/html/ge/b30/b30_users-reference-manual_4014252183.webp)
Pulse oximetry
12-7
Measurement limitations
•
The B30 monitors are designed to minimize the interference of electrosurgery. Under
some circumstances electrosurgery may cause noise on the screen. Therefore, be careful
in interpreting the results, especially the plethysmographic pulse waveform, during
electrosurgery.
•
The saturation values may be somewhat higher for smokers. Special care should be
taken with patients who have burns or carbon monoxide (CO) intoxication. When carbon
monoxide intoxication is suspected, always confirm the pulse oximetry reading with a
blood sample measurement.
•
Intravascular dyes may cause erroneous readings. For example, methylene blue, indigo
carmine, indocyanine green or any substances that contain dyes, interfere with the SpO
2
measurement.
•
Vasoconstrictive drugs, such as phenylephrine hydrochloride and dopamine, may affect
the accuracy of the measurement.
•
The pulse oximeter cannot distinguish between oxyhemoglobin and dyshemoglobins, for
example, met- or carboxyhemoglobins.
•
Poor perfusion may affect the accuracy of measurement when using the ear probe.
•
To avoid erroneous readings, do not use a blood pressure cuff or arterial blood pressure
measurement device, or NMT sensor in the same limb as the SpO
2
sensor.
Checklist
Check that
•
Only one module with pulse oximetry measurement is inserted.
•
Correct SpO
2
sensor is selected for each patient size.
•
The sensor is completely dry after cleaning.
•
Sensor or interconnect cable is plugged to the blue connector in the module.
•
Sensor is properly connected to the interconnection cable if used.
•
Sensor is positioned correctly to the patient.
•
SpO
2
is selected for screen through
Monitor Setup
-
Screen Setup
.
Summary of Contents for b30
Page 2: ......
Page 8: ......
Page 10: ...Table of contents ii...
Page 12: ...Table of contents ii...
Page 16: ...B30 Patient Monitor 4...
Page 18: ...Table of contents ii...
Page 26: ...Table of contents ii...
Page 62: ...B30 Patient Monitor 2 36...
Page 64: ...Table of contents ii...
Page 72: ...Table of contents ii...
Page 90: ...Table of contents ii...
Page 106: ...Table of contents ii...
Page 118: ...B30 Patient Monitor 6 12...
Page 120: ...Table of contents ii...
Page 124: ...B30 Patient Monitor 7 4...
Page 126: ...Table of contents ii...
Page 136: ...Table of contents ii...
Page 144: ...B30 Patient Monitor 9 8...
Page 146: ...Table of contents ii...
Page 156: ...Table of contents ii...
Page 176: ...Table of contents ii...
Page 184: ...B30 Patient Monitor 12 8...
Page 186: ...Table of contents ii...
Page 192: ...Table of contents ii...
Page 202: ...Table of contents ii...
Page 212: ...B30 Patient Monitor 15 10...
Page 214: ...Table of contents ii...
Page 224: ...B30 Patient Monitor 16 10...
Page 226: ...Table of contents ii...
Page 236: ...B30 Patient Monitor 17 10...
Page 241: ......